Drug Type Biological products |
Synonyms RCT-201 |
Target |
Action modulators |
Mechanism CFTR gene modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cystic Fibrosis | Discovery | United States | - | |
| Cystic Fibrosis | Discovery | United States | - | |
| Cystic Fibrosis | Discovery | United States | - | |
| Cystic Fibrosis | Discovery | United States | - | |
| Cystic Fibrosis | Discovery | United States | - | |
| Cystic Fibrosis | Discovery | United States | - | |
| Cystic Fibrosis | Discovery | United Kingdom | - |





